Mitochondria-targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats.
Marina VilasecaHéctor García-CalderóErica LafozMaria RuartCristina Isabel López-SanjurjoMichael P MurphyRamon DeulofeuJaume BoschVirginia Hernández-GeaJordi Gracia-SanchoJoan Carles García-PagánPublished in: Liver international : official journal of the International Association for the Study of the Liver (2017)
We propose mitochondria-targeted antioxidants as a novel treatment approach against portal hypertension and cirrhosis.